Amylin Pharmaceuticals (AMLN) dipped in early trade Friday, before settling into a range. The stock has fallen sharply in the last few minutes on increased volume and is now down 2.31 at $18.88.
Amylin Pharmaceuticals is pulling back from the highs of the year and is currently testing the lower end of a 2-week range.
For comments and feedback: editorial@rttnews.com